KNSA

Kiniksa (KNSA) is trending because ARCALYST growth keeps getting harder to dismiss

Kiniksa (KNSA) is trending because ARCALYST growth keeps getting harder to dismiss

Kiniksa Pharmaceuticals (KNSA) moved up after first-quarter 2026 results showed that ARCALYST remains a stronger commercial asset than many small-cap…

Kiniksa Pharmaceuticals International (KNSA) Reports Q1 2026 Numbers

Kiniksa Pharmaceuticals International, plc reported first-quarter results that exceeded Wall Street expectations, with the biopharmaceutical company posting diluted earnings of…

Kiniksa Pharmaceuticals Ltd (KNSA) Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) Q4 2021 Earnings Conference

Kiniksa Pharmaceuticals Ltd (KNSA) 3Q21 Earnings Call

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) Q3 2021 Earnings Conference

Kiniksa Pharmaceuticals Ltd (KNSA) Second Quarter 2021 Financial Results

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) Q2 2021 Earnings Conference